BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Theuretzbacher U, Outterson K, Engel A, Karlén A. The global preclinical antibacterial pipeline. Nat Rev Microbiol 2020;18:275-85. [PMID: 31745331 DOI: 10.1038/s41579-019-0288-0] [Cited by in Crossref: 146] [Cited by in F6Publishing: 123] [Article Influence: 48.7] [Reference Citation Analysis]
Number Citing Articles
1 Lodise TP, Bassetti M, Ferrer R, Naas T, Niki Y, Paterson DL, Zeitlinger M, Echols R. All-cause mortality rates in adults with carbapenem-resistant Gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies. Expert Rev Anti Infect Ther 2021. [PMID: 34937518 DOI: 10.1080/14787210.2022.2020099] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Wallace MJ, Fishbein SRS, Dantas G. Antimicrobial resistance in enteric bacteria: current state and next-generation solutions. Gut Microbes 2020;12:1799654. [PMID: 32772817 DOI: 10.1080/19490976.2020.1799654] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
3 Sedlmayer F, Woischnig AK, Unterreiner V, Fuchs F, Baeschlin D, Khanna N, Fussenegger M. 5-Fluorouracil blocks quorum-sensing of biofilm-embedded methicillin-resistant Staphylococcus aureus in mice. Nucleic Acids Res 2021;49:e73. [PMID: 33856484 DOI: 10.1093/nar/gkab251] [Reference Citation Analysis]
4 Matilla MA. Facing crises in the 21st century: microfluidics approaches for antibiotic discovery. Microb Biotechnol 2021. [PMID: 34333833 DOI: 10.1111/1751-7915.13908] [Reference Citation Analysis]
5 Luo F, Zeng D, Chen R, Zafar A, Weng L, Wang W, Tian Y, Hasan M, Shu X. PEGylated dihydromyricetin-loaded nanoliposomes coated with tea saponin inhibit bacterial oxidative respiration and energy metabolism. Food Funct 2021. [PMID: 34382988 DOI: 10.1039/d1fo01943k] [Reference Citation Analysis]
6 Owoicho O, Tapela K, Djomkam Zune AL, Nghochuzie NN, Isawumi A, Mosi L. Suboptimal antimicrobial stewardship in the COVID-19 era: is humanity staring at a postantibiotic future? Future Microbiol 2021;16:919-25. [PMID: 34319168 DOI: 10.2217/fmb-2021-0008] [Reference Citation Analysis]
7 Han D, Yu P, Liu X, Xu Y, Wu S. Polydopamine modified CuS@HKUST for rapid sterilization through enhanced photothermal property and photocatalytic ability. Rare Met 2022;41:663-72. [DOI: 10.1007/s12598-021-01786-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 13.0] [Reference Citation Analysis]
8 Wang X, Xu X, Zhang S, Chen N, Sun Y, Ma K, Hong D, Li L, Du Y, Lu X, Jiang S. TPGS-based and S-thanatin functionalized nanorods for overcoming drug resistance in Klebsiella pneumonia. Nat Commun 2022;13:3731. [PMID: 35768446 DOI: 10.1038/s41467-022-31500-3] [Reference Citation Analysis]
9 Annunziato G, Costantino G. Antimicrobial peptides (AMPs): a patent review (2015-2020). Expert Opin Ther Pat 2020;30:931-47. [PMID: 33187458 DOI: 10.1080/13543776.2020.1851679] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
10 Udaondo Z, Matilla MA. Mining for novel antibiotics in the age of antimicrobial resistance. Microb Biotechnol 2020;13:1702-4. [PMID: 32881368 DOI: 10.1111/1751-7915.13662] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
11 Sawant AM, Sunder AV, Vamkudoth KR, Ramasamy S, Pundle A. Process Development for 6-Aminopenicillanic Acid Production Using Lentikats-Encapsulated Escherichia coli Cells Expressing Penicillin V Acylase. ACS Omega 2020;5:28972-6. [PMID: 33225127 DOI: 10.1021/acsomega.0c02813] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
12 Dailey PJ, Elbeik T, Holodniy M. Companion and complementary diagnostics for infectious diseases. Expert Rev Mol Diagn 2020;20:619-36. [PMID: 32031431 DOI: 10.1080/14737159.2020.1724784] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Li W, Separovic F, O'Brien-Simpson NM, Wade JD. Chemically modified and conjugated antimicrobial peptides against superbugs. Chem Soc Rev 2021;50:4932-73. [PMID: 33710195 DOI: 10.1039/d0cs01026j] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 19.0] [Reference Citation Analysis]
14 Oyim J, Omolo CA, Amuhaya EK. Photodynamic Antimicrobial Chemotherapy: Advancements in Porphyrin-Based Photosensitize Development. Front Chem 2021;9:635344. [PMID: 33898388 DOI: 10.3389/fchem.2021.635344] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Moses S, Vagima Y, Tidhar A, Aftalion M, Mamroud E, Rotem S, Steinberger-Levy I. Characterization of Yersinia pestis Phage Lytic Activity in Human Whole Blood for the Selection of Efficient Therapeutic Phages. Viruses 2021;13:89. [PMID: 33440682 DOI: 10.3390/v13010089] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Frederiksen N, Hansen PR, Zabicka D, Tomczak M, Urbas M, Domraceva I, Björkling F, Franzyk H. Alternating Cationic-Hydrophobic Peptide/Peptoid Hybrids: Influence of Hydrophobicity on Antibacterial Activity and Cell Selectivity. ChemMedChem 2020;15:2544-61. [PMID: 33029927 DOI: 10.1002/cmdc.202000526] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
17 Atterbury RJ, Tyson J. Predatory bacteria as living antibiotics - where are we now? Microbiology (Reading) 2021;167. [PMID: 33465024 DOI: 10.1099/mic.0.001025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
18 Tiwari P, Khare T, Shriram V, Bae H, Kumar V. Plant synthetic biology for producing potent phyto-antimicrobials to combat antimicrobial resistance. Biotechnol Adv 2021;48:107729. [PMID: 33705914 DOI: 10.1016/j.biotechadv.2021.107729] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
19 Paracini N, Clifton LA, Lakey JH. Studying the surfaces of bacteria using neutron scattering: finding new openings for antibiotics. Biochem Soc Trans 2020;48:2139-49. [PMID: 33005925 DOI: 10.1042/BST20200320] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Tiihonen A, Cox-Vazquez SJ, Liang Q, Ragab M, Ren Z, Hartono NTP, Liu Z, Sun S, Zhou C, Incandela NC, Limwongyut J, Moreland AS, Jayavelu S, Bazan GC, Buonassisi T. Predicting Antimicrobial Activity of Conjugated Oligoelectrolyte Molecules via Machine Learning. J Am Chem Soc 2021;143:18917-31. [PMID: 34739239 DOI: 10.1021/jacs.1c05055] [Reference Citation Analysis]
21 Chow MYT, Chang RYK, Li M, Wang Y, Lin Y, Morales S, McLachlan AJ, Kutter E, Li J, Chan HK. Pharmacokinetics and Time-Kill Study of Inhaled Antipseudomonal Bacteriophage Therapy in Mice. Antimicrob Agents Chemother 2020;65:e01470-20. [PMID: 33077657 DOI: 10.1128/AAC.01470-20] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
22 Xia Y, Wang D, Liu D, Su J, Jin Y, Wang D, Han B, Jiang Z, Liu B. Applications of Chitosan and its Derivatives in Skin and Soft Tissue Diseases. Front Bioeng Biotechnol 2022;10:894667. [DOI: 10.3389/fbioe.2022.894667] [Reference Citation Analysis]
23 Imran M, Ahmad MN, Dasgupta A, Rana P, Srinivas N, Chopra S. Novel approaches for the treatment of infections due to multidrug-resistant bacterial pathogens. Future Med Chem 2022. [PMID: 35861021 DOI: 10.4155/fmc-2022-0029] [Reference Citation Analysis]
24 Song L, Hu X, Ren X, Liu J, Liu X. Antibacterial Modes of Herbal Flavonoids Combat Resistant Bacteria. Front Pharmacol 2022;13:873374. [DOI: 10.3389/fphar.2022.873374] [Reference Citation Analysis]
25 Kong Q, Li G, Zhang F, Yu T, Chen X, Jiang Q, Wang Y. N-Arylimidazoliums as Highly Selective Biomimetic Antimicrobial Agents. J Med Chem 2022. [PMID: 35930690 DOI: 10.1021/acs.jmedchem.2c00818] [Reference Citation Analysis]
26 Cama J, Leszczynski R, Tang PK, Khalid A, Lok V, Dowson CG, Ebata A. To Push or To Pull? In a Post-COVID World, Supporting and Incentivizing Antimicrobial Drug Development Must Become a Governmental Priority. ACS Infect Dis 2021;7:2029-42. [PMID: 33606496 DOI: 10.1021/acsinfecdis.0c00681] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
27 Cunningham M, Azcarate-Peril MA, Barnard A, Benoit V, Grimaldi R, Guyonnet D, Holscher HD, Hunter K, Manurung S, Obis D, Petrova MI, Steinert RE, Swanson KS, van Sinderen D, Vulevic J, Gibson GR. Shaping the Future of Probiotics and Prebiotics.Trends Microbiol. 2021;. [PMID: 33551269 DOI: 10.1016/j.tim.2021.01.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 12.0] [Reference Citation Analysis]
28 Page JE, Walker S. Natural products that target the cell envelope. Curr Opin Microbiol 2021;61:16-24. [PMID: 33662818 DOI: 10.1016/j.mib.2021.02.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
29 Vasina DV, Antonova NP, Grigoriev IV, Yakimakha VS, Lendel AM, Nikiforova MA, Pochtovyi AA, Remizov TA, Usachev EV, Shevlyagina NV, Zhukhovitsky VG, Fursov MV, Potapov VD, Vorobev AM, Aleshkin AV, Laishevtsev AI, Makarov VV, Yudin SM, Tkachuk AP, Gushchin VA. Discovering the Potentials of Four Phage Endolysins to Combat Gram-Negative Infections. Front Microbiol 2021;12:748718. [PMID: 34721353 DOI: 10.3389/fmicb.2021.748718] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Zhao C, Wang X, Yu L, Wu L, Hao X, Liu Q, Lin L, Huang Z, Ruan Z, Weng S, Liu A, Lin X. Quaternized carbon quantum dots with broad-spectrum antibacterial activity for the treatment of wounds infected with mixed bacteria. Acta Biomater 2022;138:528-44. [PMID: 34775123 DOI: 10.1016/j.actbio.2021.11.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
31 Nam J, Alam ST, Kang K, Choi J, Seo MH. Anti-staphylococcal activity of a cyclic lipopeptide, C15 -bacillomycin D, produced by Bacillus velezensis NST6. J Appl Microbiol 2021;131:93-104. [PMID: 33211361 DOI: 10.1111/jam.14936] [Reference Citation Analysis]
32 Ni C, Zhong Y, Wu W, Song Y, Makvandi P, Yu C, Song H. Co-Delivery of Nano-Silver and Vancomycin via Silica Nanopollens for Enhanced Antibacterial Functions. Antibiotics 2022;11:685. [DOI: 10.3390/antibiotics11050685] [Reference Citation Analysis]
33 Liu X, Wu Y, Mao C, Shen J, Zhu K. Host-acting antibacterial compounds combat cytosolic bacteria. Trends in Microbiology 2022. [DOI: 10.1016/j.tim.2022.01.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Tummanapalli SS, Willcox MD. Antimicrobial resistance of ocular microbes and the role of antimicrobial peptides. Clin Exp Optom 2021;104:295-307. [PMID: 32924208 DOI: 10.1111/cxo.13125] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
35 Krishnan N, Kubiatowicz LJ, Holay M, Zhou J, Fang RH, Zhang L. Bacterial membrane vesicles for vaccine applications. Adv Drug Deliv Rev 2022;185:114294. [PMID: 35436569 DOI: 10.1016/j.addr.2022.114294] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Surpeta B, Grulich M, Palyzová A, Marešová H, Brezovsky J. Common Dynamic Determinants Govern Quorum Quenching Activity in N-Terminal Serine Hydrolases. ACS Catal 2022;12:6359-74. [DOI: 10.1021/acscatal.2c00569] [Reference Citation Analysis]
37 Zhang Y, Xie C, Liu Y, Shang F, Shao R, Yu J, Wu C, Yao X, Liu D, Wang Z. Synthesis, biological activities and docking studies of pleuromutilin derivatives with piperazinyl urea linkage. J Enzyme Inhib Med Chem 2021;36:764-75. [PMID: 33733986 DOI: 10.1080/14756366.2021.1900163] [Reference Citation Analysis]
38 Ibrahim UH, Devnarain N, Govender T. Biomimetic strategies for enhancing synthesis and delivery of antibacterial nanosystems. International Journal of Pharmaceutics 2021;596:120276. [DOI: 10.1016/j.ijpharm.2021.120276] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
39 Wang J, Lin D, Liu M, Liu H, Blasco P, Sun Z, Cheung YC, Chen S, Li X. Total Synthesis of Mannopeptimycin β via β-Hydroxyenduracididine Ligation. J Am Chem Soc 2021;143:12784-90. [PMID: 34352177 DOI: 10.1021/jacs.1c05922] [Reference Citation Analysis]
40 Furuya T, Shapiro AB, Comita-Prevoir J, Kuenstner EJ, Zhang J, Ribe SD, Chen A, Hines D, Moussa SH, Carter NM, Sylvester MA, Romero JAC, Vega CV, Sacco MD, Chen Y, O'Donnell JP, Durand-Reville TF, Miller AA, Tommasi RA. N-Hydroxyformamide LpxC inhibitors, their in vivo efficacy in a mouse Escherichia coli infection model, and their safety in a rat hemodynamic assay. Bioorg Med Chem 2020;28:115826. [PMID: 33160146 DOI: 10.1016/j.bmc.2020.115826] [Reference Citation Analysis]
41 Cully M. A novel single-agent antibiotic. Nat Rev Microbiol 2021;19:743. [PMID: 34594016 DOI: 10.1038/s41579-021-00647-z] [Reference Citation Analysis]
42 Mölzer C, Heissigerova J, Wilson HM, Kuffova L, Forrester JV. Immune Privilege: The Microbiome and Uveitis. Front Immunol 2020;11:608377. [PMID: 33569055 DOI: 10.3389/fimmu.2020.608377] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
43 Bassetti M, Giacobbe DR. A look at the clinical, economic, and societal impact of antimicrobial resistance in 2020. Expert Opin Pharmacother 2020;21:2067-71. [PMID: 32749893 DOI: 10.1080/14656566.2020.1802427] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
44 Liang Y, Zhang X, Yuan Y, Bao Y, Xiong M. Role and modulation of the secondary structure of antimicrobial peptides to improve selectivity. Biomater Sci 2020;8:6858-66. [DOI: 10.1039/d0bm00801j] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
45 Spesia MB, Durantini EN. Evolution of Phthalocyanine Structures as Photodynamic Agents for Bacteria Inactivation. Chem Rec 2022;:e202100292. [PMID: 35018719 DOI: 10.1002/tcr.202100292] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
46 Zhang M, Han S, Niu X, Li H, Zhang D, Fan H, Wang K. Innovative Synthesis of PANI/Cu 2 O Nanocomposite and Its Antibacterial Properties**. ChemistrySelect 2021;6:13636-41. [DOI: 10.1002/slct.202103165] [Reference Citation Analysis]
47 Boeckaerts D, Stock M, Criel B, Gerstmans H, De Baets B, Briers Y. Predicting bacteriophage hosts based on sequences of annotated receptor-binding proteins. Sci Rep 2021;11:1467. [PMID: 33446856 DOI: 10.1038/s41598-021-81063-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
48 Paulin S, Alm RA, Beyer P. A novel pre-clinical antibacterial pipeline database. PLoS One 2020;15:e0236604. [PMID: 32722726 DOI: 10.1371/journal.pone.0236604] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
49 Turano H, Gomes F, Domingos RM, Degenhardt MFS, Oliveira CLP, Garratt RC, Lincopan N, Netto LES. Molecular Structure and Functional Analysis of Pyocin S8 from Pseudomonas aeruginosa Reveals the Essential Requirement of a Glutamate Residue in the H-N-H Motif for DNase Activity. J Bacteriol 2020;202:e00346-20. [PMID: 32817098 DOI: 10.1128/JB.00346-20] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Ramos-Vivas J, Elexpuru-Zabaleta M, Samano ML, Barrera AP, Forbes-Hernández TY, Giampieri F, Battino M. Phages and Enzybiotics in Food Biopreservation. Molecules 2021;26:5138. [PMID: 34500572 DOI: 10.3390/molecules26175138] [Reference Citation Analysis]
51 Koeninger L, Osbelt L, Berscheid A, Wendler J, Berger J, Hipp K, Lesker TR, Pils MC, Malek NP, Jensen BAH, Brötz-Oesterhelt H, Strowig T, Jan Wehkamp. Curbing gastrointestinal infections by defensin fragment modifications without harming commensal microbiota. Commun Biol 2021;4:47. [PMID: 33420317 DOI: 10.1038/s42003-020-01582-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Richter R, Lehr CM. Extracellular vesicles as novel assay tools to study cellular interactions of anti-infective compounds - A perspective. Adv Drug Deliv Rev 2021;173:492-503. [PMID: 33857554 DOI: 10.1016/j.addr.2021.04.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
53 Banahene N, Kavunja HW, Swarts BM. Chemical Reporters for Bacterial Glycans: Development and Applications. Chem Rev 2021. [PMID: 34905344 DOI: 10.1021/acs.chemrev.1c00729] [Reference Citation Analysis]
54 Zhou C, Jiang M, Ye X, Liu X, Zhao W, Ma L, Zhou C. Antibacterial Activities of Peptide HF-18 Against Helicobacter pylori and its Virulence Protein CagA. Int J Pept Res Ther 2022;28. [DOI: 10.1007/s10989-022-10372-7] [Reference Citation Analysis]
55 Ibrahim KA, Helmy OM, Kashef MT, Elkhamissy TR, Ramadan MA. Identification of Potential Drug Targets in Helicobacter pylori Using In Silico Subtractive Proteomics Approaches and Their Possible Inhibition through Drug Repurposing. Pathogens 2020;9:E747. [PMID: 32932580 DOI: 10.3390/pathogens9090747] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
56 Nolan C, Behrends V. Sub-Inhibitory Antibiotic Exposure and Virulence in Pseudomonas aeruginosa. Antibiotics (Basel) 2021;10:1393. [PMID: 34827331 DOI: 10.3390/antibiotics10111393] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Soukarieh F, Mashabi A, Richardson W, Oton EV, Romero M, Roberston SN, Grossman S, Sou T, Liu R, Halliday N, Kukavica-Ibrulj I, Levesque RC, Bergstrom CAS, Kellam B, Emsley J, Heeb S, Williams P, Stocks MJ, Cámara M. Design and Evaluation of New Quinazolin-4(3H)-one Derived PqsR Antagonists as Quorum Sensing Quenchers in Pseudomonas aeruginosa. ACS Infect Dis 2021;7:2666-85. [PMID: 34503335 DOI: 10.1021/acsinfecdis.1c00175] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
58 Oberpaul M, Brinkmann S, Marner M, Mihajlovic S, Leis B, Patras MA, Hartwig C, Vilcinskas A, Hammann PE, Schäberle TF, Spohn M, Glaeser J. Combination of high-throughput microfluidics and FACS technologies to leverage the numbers game in natural product discovery. Microb Biotechnol 2021. [PMID: 34165868 DOI: 10.1111/1751-7915.13872] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 da Silva RAG, Afonina I, Kline KA. Eradicating biofilm infections: an update on current and prospective approaches. Curr Opin Microbiol 2021;63:117-25. [PMID: 34333239 DOI: 10.1016/j.mib.2021.07.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
60 Baecker D, Sesli Ö, Knabl L, Huber S, Orth-Höller D, Gust R. Investigating the antibacterial activity of salen/salophene metal complexes: Induction of ferroptosis as part of the mode of action. Eur J Med Chem 2021;209:112907. [PMID: 33069056 DOI: 10.1016/j.ejmech.2020.112907] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
61 Iskandar K, Murugaiyan J, Hammoudi Halat D, Hage SE, Chibabhai V, Adukkadukkam S, Roques C, Molinier L, Salameh P, Van Dongen M. Antibiotic Discovery and Resistance: The Chase and the Race. Antibiotics 2022;11:182. [DOI: 10.3390/antibiotics11020182] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
62 Baker S, Kellam P, Krishna A, Reece S. Protecting intubated patients from the threat of antimicrobial resistant infections with monoclonal antibodies. Lancet Microbe 2020;1:e191-2. [PMID: 33521719 DOI: 10.1016/S2666-5247(20)30126-9] [Reference Citation Analysis]
63 Jeckelmann JM, Erni B. The mannose phosphotransferase system (Man-PTS) - Mannose transporter and receptor for bacteriocins and bacteriophages. Biochim Biophys Acta Biomembr 2020;1862:183412. [PMID: 32710850 DOI: 10.1016/j.bbamem.2020.183412] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
64 Glover RE, Singer AC, Roberts AP, Kirchhelle C. NIMble innovation—a networked model for public antibiotic trials. The Lancet Microbe 2021;2:e637-44. [DOI: 10.1016/s2666-5247(21)00182-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Duchesne C, Frescaline N, Blaise O, Lataillade JJ, Banzet S, Dussurget O, Rousseau A. Cold Atmospheric Plasma Promotes Killing of Staphylococcus aureus by Macrophages. mSphere 2021;:e0021721. [PMID: 34133202 DOI: 10.1128/mSphere.00217-21] [Reference Citation Analysis]
66 Sola R, Mardirossian M, Beckert B, Sanghez De Luna L, Prickett D, Tossi A, Wilson DN, Scocchi M. Characterization of Cetacean Proline-Rich Antimicrobial Peptides Displaying Activity against ESKAPE Pathogens. Int J Mol Sci 2020;21:E7367. [PMID: 33036159 DOI: 10.3390/ijms21197367] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
67 Browne K, Chakraborty S, Chen R, Willcox MD, Black DS, Walsh WR, Kumar N. A New Era of Antibiotics: The Clinical Potential of Antimicrobial Peptides. Int J Mol Sci 2020;21:E7047. [PMID: 32987946 DOI: 10.3390/ijms21197047] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 18.0] [Reference Citation Analysis]
68 Ushiyama F, Takashima H, Matsuda Y, Ogata Y, Sasamoto N, Kurimoto-Tsuruta R, Ueki K, Tanaka-Yamamoto N, Endo M, Mima M, Fujita K, Takata I, Tsuji S, Yamashita H, Okumura H, Otake K, Sugiyama H. Lead optimization of 2-hydroxymethyl imidazoles as non-hydroxamate LpxC inhibitors: Discovery of TP0586532. Bioorg Med Chem 2021;30:115964. [PMID: 33385955 DOI: 10.1016/j.bmc.2020.115964] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
69 Dey R, Mukherjee S, Barman S, Haldar J. Macromolecular Nanotherapeutics and Antibiotic Adjuvants to Tackle Bacterial and Fungal Infections. Macromol Biosci 2021;:e2100182. [PMID: 34351064 DOI: 10.1002/mabi.202100182] [Reference Citation Analysis]
70 Okhravi C. Economics of Public Antibiotics Development. Front Public Health 2020;8:161. [PMID: 32509716 DOI: 10.3389/fpubh.2020.00161] [Reference Citation Analysis]
71 Brandão P, Marques C, Burke AJ, Pineiro M. The application of isatin-based multicomponent-reactions in the quest for new bioactive and druglike molecules. Eur J Med Chem 2021;211:113102. [PMID: 33421712 DOI: 10.1016/j.ejmech.2020.113102] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
72 Kumar K, Singh B, Singh RP. A silver-catalyzed stereoselective domino cycloisomerization-vinylogous aldol reaction of ortho-alkynylbenzaldehydes with 3-alkylidene oxindoles: an entry to functionalized isochromenes. Chem Commun (Camb) 2020;56:15153-6. [PMID: 33210695 DOI: 10.1039/d0cc06273a] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
73 Mutalik VK, Arkin AP. A Phage Foundry Framework to Systematically Develop Viral Countermeasures to Combat Antibiotic-Resistant Bacterial Pathogens. iScience 2022;25:104121. [DOI: 10.1016/j.isci.2022.104121] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Frederiksen N, Louka S, Mudaliar C, Domraceva I, Kreicberga A, Pugovics O, Żabicka D, Tomczak M, Wygoda W, Björkling F, Franzyk H. Peptide/β-Peptoid Hybrids with Ultrashort PEG-Like Moieties: Effects on Hydrophobicity, Antibacterial Activity and Hemolytic Properties. Int J Mol Sci 2021;22:7041. [PMID: 34208826 DOI: 10.3390/ijms22137041] [Reference Citation Analysis]
75 Theuretzbacher U, Barbee L, Connolly K, Drusano G, Fernandes P, Hook E, Jerse A, O'Donnell J, Unemo M, Van Bambeke F, VanScoy B, Warn P, Werth BJ, Franceschi F, Alirol E. Pharmacokinetic/pharmacodynamic considerations for new and current therapeutic drugs for uncomplicated gonorrhoea-challenges and opportunities. Clin Microbiol Infect 2020;26:1630-5. [PMID: 32798687 DOI: 10.1016/j.cmi.2020.08.006] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
76 Anyanwu MU, Nwobi OC, Okpala COR, Ezeonu IM. Mobile Tigecycline Resistance: An Emerging Health Catastrophe Requiring Urgent One Health Global Intervention. Front Microbiol 2022;13:808744. [DOI: 10.3389/fmicb.2022.808744] [Reference Citation Analysis]
77 Mindt BC, Digiandomenico A. Microbiome Modulation as a Novel Strategy to Treat and Prevent Respiratory Infections. Antibiotics 2022;11:474. [DOI: 10.3390/antibiotics11040474] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 O'Leary MK, Chen SS, Westblade LF, Alabi CA. Design of a PEGylated Antimicrobial Prodrug with Species-Specific Activation. Biomacromolecules 2021;22:984-92. [PMID: 33428376 DOI: 10.1021/acs.biomac.0c01695] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
79 Stevens M, Howe C, Ray AM, Washburn A, Chitre S, Sivinski J, Park Y, Hoang QQ, Chapman E, Johnson SM. Analogs of nitrofuran antibiotics are potent GroEL/ES inhibitor pro-drugs. Bioorg Med Chem 2020;28:115710. [PMID: 33007545 DOI: 10.1016/j.bmc.2020.115710] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Ehmann D, Koeninger L, Wendler J, Malek NP, Stange EF, Wehkamp J, Jensen BAH. Fragmentation of Human Neutrophil α-Defensin 4 to Combat Multidrug Resistant Bacteria. Front Microbiol 2020;11:1147. [PMID: 32582092 DOI: 10.3389/fmicb.2020.01147] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
81 Fan M, Si J, Xu X, Chen L, Chen J, Yang C, Zhu J, Wu L, Tian J, Chen X, Mou X, Cai X. A versatile chitosan nanogel capable of generating AgNPs in-situ and long-acting slow-release of Ag+ for highly efficient antibacterial. Carbohydr Polym 2021;257:117636. [PMID: 33541661 DOI: 10.1016/j.carbpol.2021.117636] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
82 Gontijo AVL, Pereira SL, de Lacerda Bonfante H. Can Drug Repurposing be Effective Against Carbapenem-Resistant Acinetobacter baumannii? Curr Microbiol 2021;79:13. [PMID: 34905109 DOI: 10.1007/s00284-021-02693-5] [Reference Citation Analysis]
83 Wiecek J, Buckland-Merrett G. A View from the Wellcome Trust Drug-Resistant Infections Priority Programme: Creating a Sustainable Research and Development Ecosystem to Meet the Global Need for Antibiotics. ACS Infect Dis 2020;6:1305-7. [PMID: 32527095 DOI: 10.1021/acsinfecdis.0c00094] [Reference Citation Analysis]
84 Krell T, Matilla MA. Antimicrobial resistance: progress and challenges in antibiotic discovery and anti-infective therapy. Microb Biotechnol 2021. [PMID: 34610194 DOI: 10.1111/1751-7915.13945] [Reference Citation Analysis]
85 Mahavy CE, Duez P, ElJaziri M, Rasamiravaka T. African Plant-Based Natural Products with Antivirulence Activities to the Rescue of Antibiotics. Antibiotics (Basel) 2020;9:E830. [PMID: 33228261 DOI: 10.3390/antibiotics9110830] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
86 Moustafa DA, Wu AW, Zamora D, Daly SM, Sturge CR, Pybus C, Geller BL, Goldberg JB, Greenberg DE. Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Retain Activity against Multidrug-Resistant Pseudomonas aeruginosa In Vitro and In Vivo. mBio 2021;12:e02411-20. [PMID: 33436433 DOI: 10.1128/mBio.02411-20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
87 Sokol I, Toma M, Krnić M, Macan AM, Drenjančević D, Liekens S, Raić-Malić S, Gazivoda Kraljević T. Transition metal-catalyzed synthesis of new 3-substituted coumarin derivatives as antibacterial and cytostatic agents. Future Med Chem 2021;13:1865-84. [PMID: 34533068 DOI: 10.4155/fmc-2021-0161] [Reference Citation Analysis]
88 Stražić Novaković D, Galić N. Comprehensive degradation study of lipoglycodepsipeptide antibiotic ramoplanin by liquid chromatography and mass spectrometry. Talanta Open 2022. [DOI: 10.1016/j.talo.2022.100118] [Reference Citation Analysis]
89 Nguyen HT, Morshed MT, Vuong D, Crombie A, Lacey E, Garg S, Pi H, Woolford L, Venter H, Page SW, Piggott AM, Trott DJ, Ogunniyi AD. Evaluation of Benzguinols as Next-Generation Antibiotics for the Treatment of Multidrug-Resistant Bacterial Infections. Antibiotics (Basel) 2021;10:727. [PMID: 34208698 DOI: 10.3390/antibiotics10060727] [Reference Citation Analysis]
90 Samuelsen Ø, Åstrand OAH, Fröhlich C, Heikal A, Skagseth S, Carlsen TJO, Leiros HS, Bayer A, Schnaars C, Kildahl-Andersen G, Lauksund S, Finke S, Huber S, Gjøen T, Andresen AMS, Økstad OA, Rongved P. ZN148 Is a Modular Synthetic Metallo-β-Lactamase Inhibitor That Reverses Carbapenem Resistance in Gram-Negative Pathogens In Vivo. Antimicrob Agents Chemother 2020;64:e02415-19. [PMID: 32179522 DOI: 10.1128/AAC.02415-19] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
91 Shi Y, Wareham DW, Yuan Y, Deng X, Mata A, Azevedo HS. Polymyxin B-Triggered Assembly of Peptide Hydrogels for Localized and Sustained Release of Combined Antimicrobial Therapy. Adv Healthc Mater 2021;10:e2101465. [PMID: 34523266 DOI: 10.1002/adhm.202101465] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
92 Kim W, Prosen KR, Lepore CJ, Coukell A. On the Road to Discovering Urgently Needed Antibiotics: So Close Yet So Far Away. ACS Infect Dis 2020;6:1292-4. [PMID: 32527096 DOI: 10.1021/acsinfecdis.0c00100] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
93 Reig S, Le Gouellec A, Bleves S. What Is New in the Anti–Pseudomonas aeruginosa Clinical Development Pipeline Since the 2017 WHO Alert? Front Cell Infect Microbiol 2022;12:909731. [DOI: 10.3389/fcimb.2022.909731] [Reference Citation Analysis]
94 Loganathan A, Manohar P, Eniyan K, VinodKumar CS, Leptihn S, Nachimuthu R. Phage therapy as a revolutionary medicine against Gram-positive bacterial infections. Beni Suef Univ J Basic Appl Sci 2021;10:49. [PMID: 34485539 DOI: 10.1186/s43088-021-00141-8] [Reference Citation Analysis]
95 Xiao X, Huan Q, Huang Y, Liu Y, Li R, Xu X, Wang Z. Metformin Reverses tmexCD1-toprJ1- and tet(A)-Mediated High-Level Tigecycline Resistance in K. pneumoniae. Antibiotics 2022;11:162. [DOI: 10.3390/antibiotics11020162] [Reference Citation Analysis]
96 Stephens LJ, Werrett MV, Sedgwick AC, Bull SD, Andrews PC. Antimicrobial innovation: a current update and perspective on the antibiotic drug development pipeline. Future Medicinal Chemistry 2020;12:2035-65. [DOI: 10.4155/fmc-2020-0225] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
97 Zaknoon F, Meir O, Mor A. Mechanistic Studies of Antibiotic Adjuvants Reducing Kidney's Bacterial Loads upon Systemic Monotherapy. Pharmaceutics 2021;13:1947. [PMID: 34834362 DOI: 10.3390/pharmaceutics13111947] [Reference Citation Analysis]
98 Carratalá JV, Serna N, Villaverde A, Vázquez E, Ferrer-Miralles N. Nanostructured antimicrobial peptides: The last push towards clinics. Biotechnol Adv 2020;44:107603. [PMID: 32738381 DOI: 10.1016/j.biotechadv.2020.107603] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
99 Singh P, Pandit S, Jers C, Joshi AS, Garnæs J, Mijakovic I. Silver nanoparticles produced from Cedecea sp. exhibit antibiofilm activity and remarkable stability. Sci Rep 2021;11:12619. [PMID: 34135368 DOI: 10.1038/s41598-021-92006-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
100 Ndayishimiye J, Popat A, Blaskovich M, Falconer JR. Formulation technologies and advances for oral delivery of novel nitroimidazoles and antimicrobial peptides. J Control Release 2020;324:728-49. [PMID: 32380201 DOI: 10.1016/j.jconrel.2020.05.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
101 Zhao Y, Chen L, Wang Y, Song X, Li K, Yan X, Yu L, He Z. Nanomaterial-based strategies in antimicrobial applications: Progress and perspectives. Nano Res 2021;14:4417-41. [DOI: 10.1007/s12274-021-3417-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 14.0] [Reference Citation Analysis]
102 Ratia C, Cepas V, Soengas R, Navarro Y, Velasco-de Andrés M, Iglesias MJ, Lozano F, López-Ortiz F, Soto SM. A CS-Cyclometallated Gold(III) Complex as a Novel Antibacterial Candidate Against Drug-Resistant Bacteria. Front Microbiol 2022;13:815622. [PMID: 35308343 DOI: 10.3389/fmicb.2022.815622] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
103 Alm RA, Lahiri SD. Narrow-Spectrum Antibacterial Agents-Benefits and Challenges. Antibiotics (Basel) 2020;9:E418. [PMID: 32708925 DOI: 10.3390/antibiotics9070418] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
104 Polo AB, Fabri RL, Apolônio ACM. Searching for mechanisms of action of antimicrobials. Arch Microbiol 2020;202:2347-54. [DOI: 10.1007/s00203-020-01959-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
105 Salimi S, Akhbari K, F. Farnia SM, White JM. Sonochemical synthesis and crystal structure of copper(II)-based biodegradable antibacterial scaffold. Journal of Molecular Structure 2022;1267:133521. [DOI: 10.1016/j.molstruc.2022.133521] [Reference Citation Analysis]
106 Barreto-Santamaría A, Arévalo-Pinzón G, Patarroyo MA, Patarroyo ME. How to Combat Gram-Negative Bacteria Using Antimicrobial Peptides: A Challenge or an Unattainable Goal? Antibiotics (Basel) 2021;10:1499. [PMID: 34943713 DOI: 10.3390/antibiotics10121499] [Reference Citation Analysis]
107 Swietnicki W. Secretory System Components as Potential Prophylactic Targets for Bacterial Pathogens. Biomolecules 2021;11:892. [PMID: 34203937 DOI: 10.3390/biom11060892] [Reference Citation Analysis]
108 York A. New drugs for the antibacterial pipeline? Nat Rev Microbiol 2020;18:61. [PMID: 31797908 DOI: 10.1038/s41579-019-0310-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
109 Xia Y, Cebrián R, Xu C, Jong A, Wu W, Kuipers OP. Elucidating the mechanism by which synthetic helper peptides sensitize Pseudomonas aeruginosa to multiple antibiotics. PLoS Pathog 2021;17:e1009909. [PMID: 34478485 DOI: 10.1371/journal.ppat.1009909] [Reference Citation Analysis]
110 Wu G, Khodaparast L, Khodaparast L, De Vleeschouwer M, Housmans J, Houben B, Schymkowitz J, Rousseau F. Investigating the mechanism of action of aggregation-inducing antimicrobial Pept-ins. Cell Chem Biol 2021;28:524-536.e4. [PMID: 33434517 DOI: 10.1016/j.chembiol.2020.12.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
111 Krome AK, Becker T, Kehraus S, Schiefer A, Gütschow M, Chaverra-Muñoz L, Hüttel S, Jansen R, Stadler M, Ehrens A, Pogorevc D, Müller R, Hübner MP, Hesterkamp T, Pfarr K, Hoerauf A, Wagner KG, König GM. Corallopyronin A: antimicrobial discovery to preclinical development. Nat Prod Rep 2022. [PMID: 35730490 DOI: 10.1039/d2np00012a] [Reference Citation Analysis]
112 Cicali B, Schmidt S, Zeitlinger M, Brown JD. Macrolide Treatment Failure due to Drug–Drug Interactions: Real-World Evidence to Evaluate a Pharmacological Hypothesis. Pharmaceutics 2022;14:704. [DOI: 10.3390/pharmaceutics14040704] [Reference Citation Analysis]
113 Garcia Chavez M, Garcia A, Lee HY, Lau GW, Parker EN, Komnick KE, Hergenrother PJ. Synthesis of Fusidic Acid Derivatives Yields a Potent Antibiotic with an Improved Resistance Profile. ACS Infect Dis 2021;7:493-505. [PMID: 33522241 DOI: 10.1021/acsinfecdis.0c00869] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
114 Galac MR, Snesrud E, Lebreton F, Stam J, Julius M, Ong AC, Maybank R, Jones AR, Kwak YI, Hinkle K, Waterman PE, Lesho EP, Bennett JW, Mc Gann P. A Diverse Panel of Clinical Acinetobacter baumannii for Research and Development. Antimicrob Agents Chemother 2020;64:e00840-20. [PMID: 32718956 DOI: 10.1128/AAC.00840-20] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
115 Wan X, Hendrix H, Skurnik M, Lavigne R. Phage-based target discovery and its exploitation towards novel antibacterial molecules. Curr Opin Biotechnol 2021;68:1-7. [PMID: 33007632 DOI: 10.1016/j.copbio.2020.08.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
116 Santos-Júnior CD, Pan S, Zhao XM, Coelho LP. Macrel: antimicrobial peptide screening in genomes and metagenomes. PeerJ 2020;8:e10555. [PMID: 33384902 DOI: 10.7717/peerj.10555] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
117 Thorsing M, Krogh TJ, Vitved L, Nawrocki A, Jakobsen R, Larsen MR, Chakraborty S, Bourgeois AL, Andersen AZ, Boysen A. Linking inherent O-Linked Protein Glycosylation of YghJ to Increased Antigen Potential. Front Cell Infect Microbiol 2021;11:705468. [PMID: 34490144 DOI: 10.3389/fcimb.2021.705468] [Reference Citation Analysis]
118 Liu C, Ruan S, He Y, Li X, Zhu Y, Wang H, Huang H, Pang Z. Broad-spectrum and powerful neutralization of bacterial toxins by erythroliposomes with the help of macrophage uptake and degradation. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.03.015] [Reference Citation Analysis]
119 Fazly Bazzaz BS, Seyedi S, Hoseini Goki N, Khameneh B. Human Antimicrobial Peptides: Spectrum, Mode of Action and Resistance Mechanisms. Int J Pept Res Ther 2021;27:801-16. [DOI: 10.1007/s10989-020-10127-2] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
120 da Silva Canielles Caprara C, da Silva Freitas L, Iglesias BA, Ferreira LB, Ramos DF. Charge effect of water-soluble porphyrin derivatives as a prototype to fight infections caused by Acinetobacter baumannii by aPDT approaches. Biofouling 2022;:1-9. [PMID: 35875928 DOI: 10.1080/08927014.2022.2103804] [Reference Citation Analysis]
121 Mil-Homens D, Martins M, Barbosa J, Serafim G, Sarmento MJ, Pires RF, Rodrigues V, Bonifácio VDB, Pinto SN. Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates: In Vivo Virulence Assessment in Galleria mellonella and Potential Therapeutics by Polycationic Oligoethyleneimine. Antibiotics (Basel) 2021;10:56. [PMID: 33430101 DOI: 10.3390/antibiotics10010056] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
122 Diamantis S, Retur N, Bertrand B, Lieutier-colas F, Carenco P, Mondain V; on behalf of PROMISE Professional Community Network on Antimicrobial Resistance. The Production of Antibiotics Must Be Reoriented: Repositioning Old Narrow-Spectrum Antibiotics, Developing New Microbiome-Sparing Antibiotics. Antibiotics 2022;11:924. [DOI: 10.3390/antibiotics11070924] [Reference Citation Analysis]
123 Bendre RS, Patil RD, Patil PN, Patel HM, Sancheti RS. Synthesis and characterization of new Schiff-bases as Methicillin resistant Staphylococcus aureus (MRSA) inhibitors. Journal of Molecular Structure 2022;1252:132152. [DOI: 10.1016/j.molstruc.2021.132152] [Reference Citation Analysis]
124 Fujita K, Takata I, Yoshida I, Honma Y, Okumura H, Otake K, Takashima H, Sugiyama H. Pharmacodynamic target assessment and prediction of clinically effective dosing regimen of TP0586532, a novel non-hydroxamate LpxC inhibitor, using a murine lung infection model. Journal of Infection and Chemotherapy 2022. [DOI: 10.1016/j.jiac.2022.01.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
125 De Oliveira DMP, Forde BM, Kidd TJ, Harris PNA, Schembri MA, Beatson SA, Paterson DL, Walker MJ. Antimicrobial Resistance in ESKAPE Pathogens. Clin Microbiol Rev 2020;33:e00181-19. [PMID: 32404435 DOI: 10.1128/CMR.00181-19] [Cited by in Crossref: 103] [Cited by in F6Publishing: 77] [Article Influence: 51.5] [Reference Citation Analysis]
126 de Waure C, Calabrò GE, Ricciardi W; Value(s) of Vaccination Project Steering Committee. Recommendations to drive a value-based decision-making on vaccination. Expert Rev Vaccines 2021. [PMID: 34931919 DOI: 10.1080/14760584.2022.2021880] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
127 Rex JH, Outterson K. Antibacterial R&D at a Crossroads: We’ve Pushed as Hard as We Can … Now We Need to Start Pulling! Clinical Infectious Diseases 2020. [DOI: 10.1093/cid/ciaa852] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
128 Hu WF, Niu L, Yue XJ, Zhu LL, Hu W, Li YZ, Wu C. Characterization of Constitutive Promoters for the Elicitation of Secondary Metabolites in Myxobacteria. ACS Synth Biol 2021;10:2904-9. [PMID: 34757714 DOI: 10.1021/acssynbio.1c00444] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
129 De Maesschalck V, Gutiérrez D, Paeshuyse J, Lavigne R, Briers Y. Advanced engineering of third-generation lysins and formulation strategies for clinical applications. Crit Rev Microbiol 2020;46:548-64. [PMID: 32886565 DOI: 10.1080/1040841X.2020.1809346] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
130 Ghosh S, Mukherjee S, Patra D, Haldar J. Polymeric Biomaterials for Prevention and Therapeutic Intervention of Microbial Infections. Biomacromolecules 2022. [PMID: 35188749 DOI: 10.1021/acs.biomac.1c01528] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
131 Catalano A, Rosato A, Salvagno L, Iacopetta D, Ceramella J, Fracchiolla G, Sinicropi MS, Franchini C. Benzothiazole-Containing Analogues of Triclocarban with Potent Antibacterial Activity. Antibiotics (Basel) 2021;10:803. [PMID: 34356724 DOI: 10.3390/antibiotics10070803] [Reference Citation Analysis]
132 Reich SJ, Stohr J, Goldbeck O, Fendrich B, Crauwels P, Riedel CU. Improved fluorescent Listeria spp. biosensors for analysis of antimicrobials by flow cytometry. MicrobiologyOpen 2022;11. [DOI: 10.1002/mbo3.1304] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
133 Rimpiläinen T, Nunes A, Calado R, Fernandes AS, Andrade J, Ntungwe E, Spengler G, Szemerédi N, Rodrigues J, Gomes JP, Rijo P, Candeias NR. Increased antibacterial properties of indoline-derived phenolic Mannich bases. Eur J Med Chem 2021;220:113459. [PMID: 33915373 DOI: 10.1016/j.ejmech.2021.113459] [Reference Citation Analysis]
134 Colson AR, Morton A, Årdal C, Chalkidou K, Davies SC, Garrison LP, Jit M, Laxminarayan R, Megiddo I, Morel C, Nonvignon J, Outterson K, Rex JH, Sarker AR, Sculpher M, Woods B, Xiao Y. Antimicrobial Resistance: Is Health Technology Assessment Part of the Solution or Part of the Problem? Value Health 2021;24:1828-34. [PMID: 34838281 DOI: 10.1016/j.jval.2021.06.002] [Reference Citation Analysis]
135 Ghose C, Euler CW. Gram-Negative Bacterial Lysins. Antibiotics (Basel) 2020;9:E74. [PMID: 32054067 DOI: 10.3390/antibiotics9020074] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 10.5] [Reference Citation Analysis]
136 Pylkkö T, Ilina P, Tammela P. Development and validation of a high-content screening assay for inhibitors of enteropathogenic E. coli adhesion. J Microbiol Methods 2021;184:106201. [PMID: 33713725 DOI: 10.1016/j.mimet.2021.106201] [Reference Citation Analysis]
137 Hess J. Rational approaches towards inorganic and organometallic antibacterials. Biol Chem 2021. [PMID: 34253000 DOI: 10.1515/hsz-2021-0253] [Reference Citation Analysis]
138 Gomes NGM, Madureira-Carvalho Á, Dias-da-Silva D, Valentão P, Andrade PB. Biosynthetic versatility of marine-derived fungi on the delivery of novel antibacterial agents against priority pathogens. Biomed Pharmacother 2021;140:111756. [PMID: 34051618 DOI: 10.1016/j.biopha.2021.111756] [Reference Citation Analysis]
139 Vargas-Toscano A, Janiak C, Sabel M, Kahlert UD. A Preclinical Pipeline for Translational Precision Medicine-Experiences from a Transdisciplinary Brain Tumor Stem Cell Project. J Pers Med 2021;11:892. [PMID: 34575669 DOI: 10.3390/jpm11090892] [Reference Citation Analysis]
140 Hobson C, Chan AN, Wright GD. The Antibiotic Resistome: A Guide for the Discovery of Natural Products as Antimicrobial Agents. Chem Rev 2021;121:3464-94. [PMID: 33606500 DOI: 10.1021/acs.chemrev.0c01214] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
141 Pinto D, Gonçalo R, Louro M, Silva MS, Hernandez G, Cordeiro TN, Cordeiro C, São-José C. On the Occurrence and Multimerization of Two-Polypeptide Phage Endolysins Encoded in Single Genes. Microbiol Spectr 2022;:e0103722. [PMID: 35876588 DOI: 10.1128/spectrum.01037-22] [Reference Citation Analysis]
142 Ali W, Elsahn A, Ting DSJ, Dua HS, Mohammed I. Host Defence Peptides: A Potent Alternative to Combat Antimicrobial Resistance in the Era of the COVID-19 Pandemic. Antibiotics 2022;11:475. [DOI: 10.3390/antibiotics11040475] [Reference Citation Analysis]
143 Li Y, He X, Zhu W, Li H, Wang W. Bacterial bioluminescence assay for bioanalysis and bioimaging. Anal Bioanal Chem 2021. [PMID: 34693470 DOI: 10.1007/s00216-021-03695-9] [Reference Citation Analysis]
144 Alm RA, Gallant K. Innovation in Antimicrobial Resistance: The CARB-X Perspective. ACS Infect Dis 2020;6:1317-22. [PMID: 32202756 DOI: 10.1021/acsinfecdis.0c00026] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
145 Pacios O, Blasco L, Bleriot I, Fernandez-Garcia L, González Bardanca M, Ambroa A, López M, Bou G, Tomás M. Strategies to Combat Multidrug-Resistant and Persistent Infectious Diseases. Antibiotics (Basel) 2020;9:E65. [PMID: 32041137 DOI: 10.3390/antibiotics9020065] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 18.0] [Reference Citation Analysis]
146 Joshi AS, Singh P, Mijakovic I. Interactions of Gold and Silver Nanoparticles with Bacterial Biofilms: Molecular Interactions behind Inhibition and Resistance. Int J Mol Sci 2020;21:E7658. [PMID: 33081366 DOI: 10.3390/ijms21207658] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
147 Benítez-Chao DF, León-Buitimea A, Lerma-Escalera JA, Morones-Ramírez JR. Bacteriocins: An Overview of Antimicrobial, Toxicity, and Biosafety Assessment by in vivo Models. Front Microbiol 2021;12:630695. [PMID: 33935991 DOI: 10.3389/fmicb.2021.630695] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
148 Dai C, Lin J, Li H, Shen Z, Wang Y, Velkov T, Shen J. The Natural Product Curcumin as an Antibacterial Agent: Current Achievements and Problems. Antioxidants 2022;11:459. [DOI: 10.3390/antiox11030459] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
149 Beyer P, Paulin S. The Antibacterial Research and Development Pipeline Needs Urgent Solutions. ACS Infect Dis 2020;6:1289-91. [DOI: 10.1021/acsinfecdis.0c00044] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
150 Hardie KR. Antimicrobial resistance: the good, the bad, and the ugly. Emerg Top Life Sci 2020;4:129-36. [PMID: 32463087 DOI: 10.1042/ETLS20190194] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
151 Wang M, Feng X, Gao R, Sang P, Pan X, Wei L, Lu C, Wu C, Cai J. Modular Design of Membrane-Active Antibiotics: From Macromolecular Antimicrobials to Small Scorpionlike Peptidomimetics. J Med Chem 2021;64:9894-905. [PMID: 33789422 DOI: 10.1021/acs.jmedchem.1c00312] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
152 Wang T, Zheng Y, Dai J, Zhou J, Yu R, Zhang C. Design SMAP29-LysPA26 as a Highly Efficient Artilysin against Pseudomonas aeruginosa with Bactericidal and Antibiofilm Activity. Microbiol Spectr 2021;9:e0054621. [PMID: 34878337 DOI: 10.1128/Spectrum.00546-21] [Reference Citation Analysis]
153 Szałaj N, Benediktsdottir A, Rusin D, Karlén A, Mowbray SL, Więckowska A. Bacterial type I signal peptidase inhibitors - Optimized hits from nature. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114490] [Reference Citation Analysis]
154 Galzitskaya OV. Exploring Amyloidogenicity of Peptides From Ribosomal S1 Protein to Develop Novel AMPs. Front Mol Biosci 2021;8:705069. [PMID: 34490350 DOI: 10.3389/fmolb.2021.705069] [Reference Citation Analysis]
155 Dao TT, de Mattos-shipley KMJ, Prosser IM, Williams K, Zacharova MK, Lazarus CM, Willis CL, Bailey AM. Cleaning the Cellular Factory–Deletion of McrA in Aspergillus oryzae NSAR1 and the Generation of a Novel Kojic Acid Deficient Strain for Cleaner Heterologous Production of Secondary Metabolites. Front Fungal Biol 2021;2:632542. [DOI: 10.3389/ffunb.2021.632542] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
156 Richter R, Kamal MAM, Koch M, Niebuur BJ, Huber AL, Goes A, Volz C, Vergalli J, Kraus T, Müller R, Schneider-Daum N, Fuhrmann G, Pagès JM, Lehr CM. An Outer Membrane Vesicle-Based Permeation Assay (OMPA) for Assessing Bacterial Bioavailability. Adv Healthc Mater 2022;11:e2101180. [PMID: 34614289 DOI: 10.1002/adhm.202101180] [Reference Citation Analysis]
157 Huang Z, Zhang Z, Tong J, Malakar PK, Chen L, Liu H, Pan Y, Zhao Y. Phages and their lysins: Toolkits in the battle against foodborne pathogens in the postantibiotic era. Compr Rev Food Sci Food Saf 2021;20:3319-43. [PMID: 33938116 DOI: 10.1111/1541-4337.12757] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
158 Cebrián R, Li Q, Peñalver P, Belmonte-Reche E, Andrés-Bilbao M, Lucas R, de Paz MV, Kuipers OP, Morales JC. Chemically Tuning Resveratrol for the Effective Killing of Gram-Positive Pathogens. J Nat Prod 2022. [PMID: 35621995 DOI: 10.1021/acs.jnatprod.1c01107] [Reference Citation Analysis]
159 Clancy CJ, Nguyen MH. Buying Time: The AMR Action Fund and the State of Antibiotic Development in the United States 2020. Open Forum Infect Dis 2020;7:ofaa464. [PMID: 33209952 DOI: 10.1093/ofid/ofaa464] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
160 Nyerges A, Tomašič T, Durcik M, Revesz T, Szili P, Draskovits G, Bogar F, Skok Ž, Zidar N, Ilaš J, Zega A, Kikelj D, Daruka L, Kintses B, Vasarhelyi B, Foldesi I, Kata D, Welin M, Kimbung R, Focht D, Mašič LP, Pal C. Rational design of balanced dual-targeting antibiotics with limited resistance. PLoS Biol 2020;18:e3000819. [PMID: 33017402 DOI: 10.1371/journal.pbio.3000819] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
161 Gerstmans H, Grimon D, Gutiérrez D, Lood C, Rodríguez A, van Noort V, Lammertyn J, Lavigne R, Briers Y. A VersaTile-driven platform for rapid hit-to-lead development of engineered lysins. Sci Adv 2020;6:eaaz1136. [PMID: 32537492 DOI: 10.1126/sciadv.aaz1136] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 15.0] [Reference Citation Analysis]
162 Riu F, Ruda A, Ibba R, Sestito S, Lupinu I, Piras S, Widmalm G, Carta A. Antibiotics and Carbohydrate-Containing Drugs Targeting Bacterial Cell Envelopes: An Overview. Pharmaceuticals 2022;15:942. [DOI: 10.3390/ph15080942] [Reference Citation Analysis]
163 Klug DM, Idiris FIM, Blaskovich MAT, von Delft F, Dowson CG, Kirchhelle C, Roberts AP, Singer AC, Todd MH. There is no market for new antibiotics: this allows an open approach to research and development. Wellcome Open Res 2021;6:146. [PMID: 34250265 DOI: 10.12688/wellcomeopenres.16847.1] [Reference Citation Analysis]
164 Yang S, Wang Y, Tan J, Teo JY, Tan KH, Yang YY. Antimicrobial Polypeptides Capable of Membrane Translocation for Treatment of MRSA Wound Infection In Vivo. Adv Healthc Mater 2022;11:e2101770. [PMID: 34846807 DOI: 10.1002/adhm.202101770] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
165 Azad MAK, Zhang S, Li J, Kim Y, Yu HH, Fulcher AJ, Howard DL, de Jonge MD, James SA, Roberts KD, Velkov T, Fu J, Zhou QT, Li J. Synchrotron-based X-ray fluorescence microscopy reveals accumulation of polymyxins in single human alveolar epithelial cells. Antimicrob Agents Chemother 2021:AAC. [PMID: 33649114 DOI: 10.1128/AAC.02314-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
166 Li H, Maimaitiming M, Zhou Y, Li H, Wang P, Liu Y, Schäberle TF, Liu Z, Wang C. Discovery of Marine Natural Products as Promising Antibiotics against Pseudomonas aeruginosa. Marine Drugs 2022;20:192. [DOI: 10.3390/md20030192] [Reference Citation Analysis]
167 Singh R, Hano C, Tavanti F, Sharma B. Biogenic Synthesis and Characterization of Antioxidant and Antimicrobial Silver Nanoparticles Using Flower Extract of Couroupita guianensis Aubl. Materials (Basel) 2021;14:6854. [PMID: 34832255 DOI: 10.3390/ma14226854] [Reference Citation Analysis]
168 Ngiam L, Schembri MA, Weynberg K, Guo J. Bacteriophage isolated from non-target bacteria demonstrates broad host range infectivity against multidrug-resistant bacteria. Environ Microbiol 2021. [PMID: 34390602 DOI: 10.1111/1462-2920.15714] [Reference Citation Analysis]
169 Upert G, Luther A, Obrecht D, Ermert P. Emerging peptide antibiotics with therapeutic potential. Med Drug Discov 2021;9:100078. [PMID: 33398258 DOI: 10.1016/j.medidd.2020.100078] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
170 Sorgenfrei M, Hürlimann LM, Remy MM, Keller PM, Seeger MA. Biomolecules capturing live bacteria from clinical samples. Trends Biochem Sci 2022:S0968-0004(22)00077-9. [PMID: 35487808 DOI: 10.1016/j.tibs.2022.03.018] [Reference Citation Analysis]
171 Zhang Q, Chen S, Liu X, Lin W, Zhu K. Equisetin Restores Colistin Sensitivity against Multi-Drug Resistant Gram-Negative Bacteria. Antibiotics (Basel) 2021;10:1263. [PMID: 34680843 DOI: 10.3390/antibiotics10101263] [Reference Citation Analysis]
172 Cao Z, Chen X, Chen J, Xia A, Bacacao B, Tran J, Sharma D, Bekale LA, Santa Maria PL. Gold nanocluster adjuvant enables the eradication of persister cells by antibiotics and abolishes the emergence of resistance. Nanoscale 2022;14:10016-32. [PMID: 35796201 DOI: 10.1039/d2nr01003h] [Reference Citation Analysis]
173 Saha P, Sikdar S, Krishnamoorthy G, Zgurskaya HI, Rybenkov VV. Drug Permeation against Efflux by Two Transporters. ACS Infect Dis 2020;6:747-58. [PMID: 32039579 DOI: 10.1021/acsinfecdis.9b00510] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
174 Cebrián R, Belmonte-Reche E, Pirota V, de Jong A, Morales JC, Freccero M, Doria F, Kuipers OP. G-Quadruplex DNA as a Target in Pathogenic Bacteria: Efficacy of an Extended Naphthalene Diimide Ligand and Its Mode of Action. J Med Chem 2021. [PMID: 34928608 DOI: 10.1021/acs.jmedchem.1c01905] [Reference Citation Analysis]
175 Gouveia A, Pinto D, Veiga H, Antunes W, Pinho MG, São-José C. Synthetic antimicrobial peptides as enhancers of the bacteriolytic action of staphylococcal phage endolysins. Sci Rep 2022;12:1245. [PMID: 35075218 DOI: 10.1038/s41598-022-05361-1] [Reference Citation Analysis]
176 Li M, Azad MAK, Ahmed MU, Zhu Y, Song J, Zhou F, Chan H, Velkov T, Zhou QT, Li J. Polymyxin Induces Significant Transcriptomic Perturbations of Cellular Signalling Networks in Human Lung Epithelial Cells. Antibiotics 2022;11:307. [DOI: 10.3390/antibiotics11030307] [Reference Citation Analysis]
177 Beha MJ, Ryu JS, Kim YS, Chung HJ. Delivery of antisense oligonucleotides using multi-layer coated gold nanoparticles to methicillin-resistant S. aureus for combinatorial treatment. Mater Sci Eng C Mater Biol Appl 2021;126:112167. [PMID: 34082968 DOI: 10.1016/j.msec.2021.112167] [Reference Citation Analysis]
178 Xian PJ, Liu SZ, Wang WJ, Yang SX, Feng Z, Yang XL. Undescribed specialised metabolites from the endophytic fungus Emericella sp. XL029 and their antimicrobial activities. Phytochemistry 2022;:113303. [PMID: 35787351 DOI: 10.1016/j.phytochem.2022.113303] [Reference Citation Analysis]
179 Katiki M, Neetu N, Pratap S, Kumar P. Biochemical and structural basis for Moraxella catarrhalis enoyl-acyl carrier protein reductase (FabI) inhibition by triclosan and estradiol. Biochimie 2022:S0300-9084(22)00046-3. [PMID: 35276316 DOI: 10.1016/j.biochi.2022.02.008] [Reference Citation Analysis]
180 Drayton M, Deisinger JP, Ludwig KC, Raheem N, Müller A, Schneider T, Straus SK. Host Defense Peptides: Dual Antimicrobial and Immunomodulatory Action. Int J Mol Sci 2021;22:11172. [PMID: 34681833 DOI: 10.3390/ijms222011172] [Reference Citation Analysis]
181 Bapolisi AM, Kielb P, Bekir M, Lehnen AC, Radon C, Laroque S, Wendler P, Müller-Werkmeister HM, Hartlieb M. Antimicrobial Polymers of Linear and Bottlebrush Architecture: Probing the Membrane Interaction and Physicochemical Properties. Macromol Rapid Commun 2022;:e2200288. [PMID: 35686622 DOI: 10.1002/marc.202200288] [Reference Citation Analysis]
182 Vázquez R, García E, García P. Sequence-Function Relationships in Phage-Encoded Bacterial Cell Wall Lytic Enzymes and Their Implications for Phage-Derived Product Design. J Virol 2021;95:e0032121. [PMID: 33883227 DOI: 10.1128/JVI.00321-21] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
183 Vicente-García C, Colomer I. New antimicrobial self-assembling short lipopeptides. Org Biomol Chem 2021;19:6797-803. [PMID: 34319330 DOI: 10.1039/d1ob01227d] [Reference Citation Analysis]
184 Babic N, Kovacic F. Predicting drug targets by homology modelling of Pseudomonas aeruginosa proteins of unknown function. PLoS One 2021;16:e0258385. [PMID: 34648550 DOI: 10.1371/journal.pone.0258385] [Reference Citation Analysis]
185 Prasad NK, Seiple IB, Cirz RT, Rosenberg OS. Leaks in the Pipeline: a Failure Analysis of Gram-Negative Antibiotic Development from 2010 to 2020. Antimicrob Agents Chemother 2022;:e0005422. [PMID: 35471042 DOI: 10.1128/aac.00054-22] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
186 Hetrick KJ, Aguilar Ramos MA, Raines RT. Endogenous Enzymes Enable Antimicrobial Activity. ACS Chem Biol 2021;16:800-5. [PMID: 33877811 DOI: 10.1021/acschembio.0c00894] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
187 Escobar‐salom M, Torrens G, Jordana‐lluch E, Oliver A, Juan C. Mammals' humoral immune proteins and peptides targeting the bacterial envelope: from natural protection to therapeutic applications against multidrug‐resistant Gram ‐negatives. Biological Reviews. [DOI: 10.1111/brv.12830] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
188 Ribeiro CFA, Silveira GGOS, Cândido ES, Cardoso MH, Espínola Carvalho CM, Franco OL. Effects of Antibiotic Treatment on Gut Microbiota and How to Overcome Its Negative Impacts on Human Health. ACS Infect Dis 2020;6:2544-59. [PMID: 32786282 DOI: 10.1021/acsinfecdis.0c00036] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
189 Miethke M, Pieroni M, Weber T, Brönstrup M, Hammann P, Halby L, Arimondo PB, Glaser P, Aigle B, Bode HB, Moreira R, Li Y, Luzhetskyy A, Medema MH, Pernodet JL, Stadler M, Tormo JR, Genilloud O, Truman AW, Weissman KJ, Takano E, Sabatini S, Stegmann E, Brötz-Oesterhelt H, Wohlleben W, Seemann M, Empting M, Hirsch AKH, Loretz B, Lehr CM, Titz A, Herrmann J, Jaeger T, Alt S, Hesterkamp T, Winterhalter M, Schiefer A, Pfarr K, Hoerauf A, Graz H, Graz M, Lindvall M, Ramurthy S, Karlén A, van Dongen M, Petkovic H, Keller A, Peyrane F, Donadio S, Fraisse L, Piddock LJV, Gilbert IH, Moser HE, Müller R. Towards the sustainable discovery and development of new antibiotics. Nat Rev Chem 2021;:1-24. [PMID: 34426795 DOI: 10.1038/s41570-021-00313-1] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
190 Zscherp R, Coetzee J, Vornweg J, Grunenberg J, Herrmann J, Müller R, Klahn P. Biomimetic enterobactin analogue mediates iron-uptake and cargo transport into E. coli and P. aeruginosa. Chem Sci 2021;12:10179-90. [PMID: 34377407 DOI: 10.1039/d1sc02084f] [Reference Citation Analysis]
191 Briot T, Kolenda C, Ferry T, Medina M, Laurent F, Leboucher G, Pirot F; PHAGEinLYON study group. Paving the way for phage therapy using novel drug delivery approaches. J Control Release 2022;347:414-24. [PMID: 35569589 DOI: 10.1016/j.jconrel.2022.05.021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
192 Bann SJ, Ballantine RD, Cochrane SA. The tridecaptins: non-ribosomal peptides that selectively target Gram-negative bacteria. RSC Med Chem 2021;12:538-51. [PMID: 34041489 DOI: 10.1039/d0md00413h] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
193 Setiawan E, Cotta MO, Abdul-Aziz MH, Sosilya H, Widjanarko D, Wardhani DK, Roberts JA. Indonesian healthcare providers' perceptions and attitude on antimicrobial resistance, prescription and stewardship programs. Future Microbiol 2022. [PMID: 35212232 DOI: 10.2217/fmb-2021-0193] [Reference Citation Analysis]
194 Minias A, Żukowska L, Lechowicz E, Gąsior F, Knast A, Podlewska S, Zygała D, Dziadek J. Early Drug Development and Evaluation of Putative Antitubercular Compounds in the -Omics Era. Front Microbiol 2020;11:618168. [PMID: 33603720 DOI: 10.3389/fmicb.2020.618168] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
195 Ciabuschi F, Baraldi E, Lindahl O. Joining Forces to Prevent the Antibiotic Resistance Doomsday Scenario: The Rise of International Multisectoral Partnerships as a New Governance Model. AMP 2020;34:458-79. [DOI: 10.5465/amp.2019.0018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
196 Just-Baringo X, Yeste-Vázquez A, Moreno-Morales J, Ballesté-Delpierre C, Vila J, Giralt E. Controlling Antibacterial Activity Exclusively with Visible Light: Introducing a Tetra-ortho-Chloro-Azobenzene Amino Acid. Chemistry 2021;27:12987-91. [PMID: 34227716 DOI: 10.1002/chem.202102370] [Reference Citation Analysis]
197 Shlaes DM. Innovation, Nontraditional Antibacterial Drugs, and Clinical Utility. ACS Infect Dis 2021;7:2027-8. [PMID: 33979122 DOI: 10.1021/acsinfecdis.1c00227] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
198 Jensen SK, Thomsen TT, Oddo A, Franzyk H, Løbner-Olesen A, Hansen PR. Novel Cyclic Lipopeptide Antibiotics: Effects of Acyl Chain Length and Position. Int J Mol Sci 2020;21:E5829. [PMID: 32823798 DOI: 10.3390/ijms21165829] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
199 Blair DJ, Burke MD. Modular synthesis enables molecular ju-jitsu in the fight against antibiotic resistance. Nature 2020;586:32-3. [DOI: 10.1038/d41586-020-02565-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
200 Wang Z, Liu X, Duan Y, Huang Y. Infection microenvironment-related antibacterial nanotherapeutic strategies. Biomaterials 2022;280:121249. [PMID: 34801252 DOI: 10.1016/j.biomaterials.2021.121249] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
201 Murphy RA, Coates M, Thrane S, Sabnis A, Harrison J, Schelenz S, Edwards AM, Vorup-Jensen T, Davies JC. Synergistic Activity of Repurposed Peptide Drug Glatiramer Acetate with Tobramycin against Cystic Fibrosis Pseudomonas aeruginosa. Microbiol Spectr 2022;:e0081322. [PMID: 35727066 DOI: 10.1128/spectrum.00813-22] [Reference Citation Analysis]
202 Jampilek J. Drug repurposing to overcome microbial resistance. Drug Discov Today 2022:S1359-6446(22)00193-3. [PMID: 35561965 DOI: 10.1016/j.drudis.2022.05.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
203 Sahoo A, Swain SS, Behera A, Sahoo G, Mahapatra PK, Panda SK. Antimicrobial Peptides Derived From Insects Offer a Novel Therapeutic Option to Combat Biofilm: A Review. Front Microbiol 2021;12:661195. [PMID: 34248873 DOI: 10.3389/fmicb.2021.661195] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
204 Zhu Y, Hao W, Wang X, Ouyang J, Deng X, Yu H, Wang Y. Antimicrobial peptides, conventional antibiotics, and their synergistic utility for the treatment of drug-resistant infections. Med Res Rev 2022. [PMID: 34984699 DOI: 10.1002/med.21879] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
205 Ploy MC, Andremont A, Valtier B, Le Jeunne C; participants of Giens XXXV Round Table 'Translational research'. Antibiotic resistance: Tools for effective translational research. Therapie 2020;75:7-12. [PMID: 31987590 DOI: 10.1016/j.therap.2019.12.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
206 Liu J, Li RS, He M, Xu Z, Xu LQ, Kang Y, Xue P. Multifunctional SGQDs-CORM@HA nanosheets for bacterial eradication through cascade-activated "nanoknife" effect and photodynamic/CO gas therapy. Biomaterials 2021;277:121084. [PMID: 34454374 DOI: 10.1016/j.biomaterials.2021.121084] [Reference Citation Analysis]
207 De Oliveira DMP, Forde BM, Phan M, Steiner B, Zhang B, Zuegg J, El-deeb IM, Li G, Keller N, Brouwer S, Harbison-price N, Cork AJ, Bauer MJ, Alquethamy SF, Beatson SA, Roberts JA, Paterson DL, Mcewan AG, Blaskovich MAT, Schembri MA, Mcdevitt CA, von Itzstein M, Walker MJ, Ballard JD. Rescuing Tetracycline Class Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii Pulmonary Infection. mBio 2022;13:e03517-21. [DOI: 10.1128/mbio.03517-21] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
208 Mohammed EHM, Lohan S, Tiwari RK, Parang K. Amphiphilic cyclic peptide [W4KR5]-Antibiotics combinations as broad-spectrum antimicrobial agents. Eur J Med Chem 2022;235:114278. [PMID: 35339840 DOI: 10.1016/j.ejmech.2022.114278] [Reference Citation Analysis]
209 Vasina DV, Antonova NP, Vorobev AM, Laishevtsev AI, Kapustin AV, Zulkarneev ER, Bochkareva SS, Kiseleva IA, Anurova MN, Aleshkin AV, Tkachuk AP, Gushchin VA. Efficacy of the Endolysin-Based Antibacterial Gel for Treatment of Anaerobic Infection Caused by Fusobacterium necrophorum. Antibiotics (Basel) 2021;10:1260. [PMID: 34680839 DOI: 10.3390/antibiotics10101260] [Reference Citation Analysis]
210 Mather JC, Wyllie JA, Hamilton A, Soares da Costa TP, Barnard PJ. Antibacterial silver and gold complexes of imidazole and 1,2,4-triazole derived N-heterocyclic carbenes. Dalton Trans 2022. [PMID: 35876319 DOI: 10.1039/d2dt01657e] [Reference Citation Analysis]
211 Benediktsdottir A, Lu L, Cao S, Zamaratski E, Karlén A, Mowbray SL, Hughes D, Sandström A. Antibacterial sulfonimidamide-based oligopeptides as type I signal peptidase inhibitors: Synthesis and biological evaluation. Eur J Med Chem 2021;224:113699. [PMID: 34352713 DOI: 10.1016/j.ejmech.2021.113699] [Reference Citation Analysis]
212 Vanamala K, Tatiparti K, Bhise K, Sau S, Scheetz MH, Rybak MJ, Andes D, Iyer AK. Novel approaches for the treatment of methicillin-resistant Staphylococcus aureus: Using nanoparticles to overcome multidrug resistance. Drug Discov Today 2021;26:31-43. [PMID: 33091564 DOI: 10.1016/j.drudis.2020.10.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]